ERNA vs TT · P/E 0.0, rev $582.0K vs P/E 36, rev $21.32B
Eterna Therapeutics Inc (ERNA) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the ERNA and TT stock pages for the full models.
Not investment advice.